NCT06178783View on ClinicalTrials.gov

A Study of the Palatability and Acceptability of Different Brensocatib Oral Liquid Formulations in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

December 27, 2023

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions

Healthy Volunteers

Interventions

DRUG

Brensocatib

Brensocatib oral solutions will be expectorated following the tasting.

Trial Locations (1)

75247

USA001, Dallas

All Listed Sponsors

lead

Insmed Incorporated

INDUSTRY